UBS discusses taxes, spending, debt, and deficits under Trump 2.0
Investing.com — As President-elect Donald Trump prepares to embark on his second term, UBS analysts foresee constraints shaping the fiscal...
UBS doesn’t see significant change in the US deficit under Trump 2.0
Investing.com — A second Trump administration is likely to see little change in the U.S. fiscal deficit, despite campaign promises...
Trump taps ex-Treasury official Miran as chair of Council of Economic Advisers
WASHINGTON (Reuters) – Stephen Miran, who was an adviser for economic policy at the U.S. Treasury Department when Donald Trump...
Singapore Post fires CEO over handling of whistleblower report
(Reuters) -Singapore Post said on Sunday it had dismissed its chief executive and two other senior managers after an internal...
Crude oil missing catalyst to lift prices; what’s next for the market?
The crude oil market seems as though it is waiting for a catalyst to break out of its current tight...
These 2 stocks are positioned to outperform in January
Thwarted expectations of up to 4 rate cuts in 2025 have sent US stocks tumbling down in recent days. But...
Top 3 best ETFs for value investors in 2025
Exchange-traded funds (ETFs) had a strong performance in 2024 as inflows surged by over $1 trillion. Most of these inflows...
Southeast Asia lags behind in AI funding despite $60 billion global boom
Southeast Asia, a region of over 675 million people, is emerging as a focal point for global investment in cloud...
Hubspot stock price slowly forms a bullish pattern: what next?
Hubspot stock price has done well this year and is loitering near its highest level since December 2021. HUBS was...
Humacyte stock may fail to sustain today’s gains: find out more
Shares of Humacyte Inc (NASDAQ: HUMA) nearly doubled on Friday after receiving full approval for its flagship SYMVESS product from...
